De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry

Debu Tripathy, Adam Brufsky, Melody Cobleigh, Mohammad Jahanzeb, Peter A. Kaufman, Ginny Mason, Joyce O'Shaughnessy, Hope S. Rugo, Sandra M. Swain, Denise A. Yardley, Laura Chu, Haocheng Li, Vincent Antao, Sara A. Hurvitz

Research output: Contribution to journal › Article › peer-review

38 Scopus citations

Fingerprint

Dive into the research topics of 'De Novo Versus Recurrent HER2-Positive Metastatic Breast Cancer: Patient Characteristics, Treatment, and Survival from the SystHERs Registry'. Together they form a unique fingerprint.

Medicine & Life Sciences